An Open Label, Randomized, Controlled, Phase III, Multi-Center, Clinical Trial Of PN401 With High Dose 5-Fluorouracil (5FU) Versus Gemcitabine For Treatment Of Patients With Advanced Pancreatic Cancer.

Trial Profile

An Open Label, Randomized, Controlled, Phase III, Multi-Center, Clinical Trial Of PN401 With High Dose 5-Fluorouracil (5FU) Versus Gemcitabine For Treatment Of Patients With Advanced Pancreatic Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jun 2012

At a glance

  • Drugs Fluorouracil; Gemcitabine; Uridine triacetate
  • Indications Pancreatic cancer
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Most Recent Events

    • 27 Jun 2012 Actual patient number is 250 according to ClinicalTrials.gov.
    • 18 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 May 2010 Actual end date (Feb 2006) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top